$ Value
$231
Shares
88
Price
$3
Filed
Sep 24
Insider
Name
Saccomano Nicholas A
Title
President and CEO
CIK
0001609284
Roles
Transaction Details
Transaction Date
2025-09-22
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
3,506
Footnotes
These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan. | This transaction was executed in multiple trades at prices ranging from $2.60 to $2.645. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
Filing Info
Saccomano Nicholas A's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | OKUR | A | $0 |
| 2026-03-23 | OKUR | ▼ | $357 |
| 2025-12-22 | OKUR | ▼ | $258 |
| 2025-09-22 | OKUR | ▼ | $231 |
| 2025-06-23 | OKUR | ▼ | $210 |
Other Insiders at OKUR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Ratcliffe Liam | — | — | 2026-03-31 |
|
Saccomano Nicholas A
President and CEO
|
— | $357 | 2026-04-01 |
|
Leverone Jason A.
Chief Financial Officer
|
— | $1K | 2026-04-01 |
|
Agresta Samuel
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Hartley Dylan
Chief Scientific Officer
|
— | — | 2026-04-01 |